You are here

AVAC's Blog: P-Values

Malawi was listed as one of the six locations that have made remarkable progress towards ending the AIDS epidemic in a recent report produced by amfAR, AVAC and Friends of the Global Fight. Being one of the poorest countries on the list, Malawi has proven that ending the epidemic is possible anywhere.

The Advocacy-for-Cure Academy, a partnership of AVAC and IAS, has been developing its cutting-edge curriculum, having completed two annual sessions and promising more in the years to come, just as the field of cure research and advocacy has accelerated on the heels of high-profile breakthroughs.

The World Health Organization (WHO) released updated guidance on “Hormonal Contraceptive Eligibility for Women at High Risk of HIV”. We are gravely concerned that this guidance will be used to justify a “business as usual” approach in which contraceptive procurement, program design, service delivery and counseling approaches go unchanged.

A new daily oral PrEP strategy using F/TAF, inched a step closer to availability—though not necessarily for all people who need it. This blog provides information on what happened at an Antimicrobial Drugs Advisory Committee meeting on F/TAF for PrEP, convened by the US Food and Drug Administration—and what needs to happen next.

As AVAC prepares for our 2020 Fellows Program, watch this space for information about activities and an evaluation marking 10 years of impact on HIV prevention advocacy and to chart the way forward for the program.

The Resource Tracking for HIV Prevention R&D Working Group has launched its 15th annual report, HIV Prevention Research & Development Investments: Investing to end the epidemic, detailing overall 2018 investment and analysis of funding trends. And the Cure Resource Tracking Group has also released its annual report, Global Investment in HIV Cure Research and Development in 2018.

AVAC is pleased to share a new report, Translating Progress into Success to End the AIDS Epidemic, produced in collaboration with amfAR and Friends of the Global Fight against AIDS, Tuberculosis and Malaria.